Results 241 to 250 of about 20,880 (290)

Hospital‐Based Cross‐Sectional Study of Burkholderia pseudomallei Seroreactivity Among Febrile Patients in Northernmost Vietnam: Near‐Neighbor Bloodstream Isolates, Environmental Correlates, and Spatial Clustering

GeoHealth, Volume 10, Issue 6, June 2026.
Abstract Melioidosis is a potentially fatal tropical disease caused by the environmentally mediated bacterium, Burkholderia pseudomallei. In Vietnam, melioidosis is not nationally reportable and little is known regarding its epidemiology and distribution in the northernmost mountainous provinces.
Morgan C. Metrailer, Tran Thi Le Quyen, Khang Van Pham, Tan Minh Luong, Treenate Jiranantasak, Andrew P. Bluhm, Frank J. Tuozzo II, Thi Thu Ha Hoang, Minh Hoa Luong, Bich Ngoc Do, Thanh Hai Pham, Madison E. A. Harman, Michael H. Norris, Trinh Thanh Trung, Jason K. Blackburn   +14 more
wiley   +1 more source

Geologically Recent Formation of Some Tesserae on Venus by Plains Deformation

Journal of Geophysical Research: Planets, Volume 131, Issue 6, June 2026.
Abstract Tessera is a pervasively deformed terrain type on Venus generally interpreted as the oldest preserved material on the surface. Large expanses of this terrain type are typically elevated and have been hypothesized to be felsic, perhaps analogous to Earth's continents and even to date from an era with a more Earth‐like climate earlier in Venus ...
Paul K. Byrne, Christian Klimczak, Kelsey T. Crane, Peter B. James, Richard C. Ghail, A. M. Celâl Şengör, Sean C. Solomon   +6 more
wiley   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Quizartinib is an oral, potent, selective FMS‐like tyrosine kinase 3 (FLT3) inhibitor, approved for the treatment of FLT3‐internal tandem duplication (ITD)–positive acute myeloid leukemia (AML) and under investigation in patients with newly diagnosed FLT3‐ITD–negative AML.
YoungJun Yoo, Hamim Zahir, Shinichi Inaba, Kyoin Koo, Tushar Garimella, Malaz Abutarif, Ming Zheng, Emi Kamiyama, Yuan Xu   +8 more
wiley   +1 more source

Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Nacubactam is a β‐lactamase inhibitor. Early‐phase studies with 1000/2000/4000/8000 mg nacubactam monotherapy were not powered to assess proarrhythmic risk. Therefore, this analysis pooled electrocardiogram data from two placebo‐controlled studies to quantify potential effects of nacubactam on cardiac repolarization.
Jun Morita, Sue McKendrick, Yuji Kumagai
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source